207 related articles for article (PubMed ID: 35036891)
1. Impact of autoimmune serology test results on RA classification and diagnosis.
Van Hoovels L; Studenic P; Sieghart D; Steiner G; Bossuyt X; Rönnelid J
J Transl Autoimmun; 2022; 5():100142. PubMed ID: 35036891
[TBL] [Abstract][Full Text] [Related]
2. Performance characteristics of rheumatoid factor and anti-cyclic citrullinated peptide antibody assays may impact ACR/EULAR classification of rheumatoid arthritis.
Van Hoovels L; Jacobs J; Vander Cruyssen B; Van den Bremt S; Verschueren P; Bossuyt X
Ann Rheum Dis; 2018 May; 77(5):667-677. PubMed ID: 29363510
[TBL] [Abstract][Full Text] [Related]
3. Multicentre study to improve clinical interpretation of rheumatoid factor and anti-citrullinated protein/peptide antibodies test results.
Van Hoovels L; Vander Cruyssen B; Sieghart D; Bonroy C; Nagy E; Pullerits R; Čučnik S; Dahle C; Heijnen I; Bernasconi L; Benkhadra F; Bogaert L; Van Den Bremt S; Van Liedekerke A; Vanheule G; Robbrecht J; Studholme L; Wirth C; Müller R; Kyburz D; Sjöwall C; Kastbom A; Ješe R; Jovancevic B; Kiss E; Jacques P; Aletaha D; Steiner G; Verschueren P; Bossuyt X
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35321875
[TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in Rheumatoid Arthritis - Laboratory and Clinical Perspectives.
Rönnelid J; Turesson C; Kastbom A
Front Immunol; 2021; 12():685312. PubMed ID: 34054878
[TBL] [Abstract][Full Text] [Related]
5. The diagnostic utility of rheumatoid factor and anticitrullinated protein antibody for rheumatoid arthritis in the Indian population.
Kumar A; Vasdev V; Patnaik SK; Bhatt S; Singh R; Bhayana A; Hegde A; Kumar A
Med J Armed Forces India; 2022 Sep; 78(Suppl 1):S69-S74. PubMed ID: 36147402
[TBL] [Abstract][Full Text] [Related]
6. Determination of Autoantibody Isotypes Increases the Sensitivity of Serodiagnostics in Rheumatoid Arthritis.
Sieghart D; Platzer A; Studenic P; Alasti F; Grundhuber M; Swiniarski S; Horn T; Haslacher H; Blüml S; Smolen J; Steiner G
Front Immunol; 2018; 9():876. PubMed ID: 29740454
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Serological Biomarkers in Rheumatoid Arthritis and Their Combination to Improve Diagnostic Performance.
Martinez-Prat L; Nissen MJ; Lamacchia C; Bentow C; Cesana L; Roux-Lombard P; Gabay C; Mahler M
Front Immunol; 2018; 9():1113. PubMed ID: 29928272
[TBL] [Abstract][Full Text] [Related]
8. Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.
Hiwa R; Ohmura K; Nakabo S; Terao C; Murakami K; Nakashima R; Imura Y; Yukawa N; Yoshifuji H; Hashimoto M; Furu M; Ito H; Fujii T; Mimori T
Int J Rheum Dis; 2017 Jun; 20(6):731-736. PubMed ID: 28198158
[TBL] [Abstract][Full Text] [Related]
9. Presence of autoantibodies in "seronegative" rheumatoid arthritis associates with classical risk factors and high disease activity.
Reed E; Hedström AK; Hansson M; Mathsson-Alm L; Brynedal B; Saevarsdottir S; Cornillet M; Jakobsson PJ; Holmdahl R; Skriner K; Serre G; Alfredsson L; Rönnelid J; Lundberg K
Arthritis Res Ther; 2020 Jul; 22(1):170. PubMed ID: 32678001
[TBL] [Abstract][Full Text] [Related]
10. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
[TBL] [Abstract][Full Text] [Related]
11. Serum anti-citrullinated protein antibodies and rheumatoid factor increase the risk of rheumatoid arthritis-related interstitial lung disease: a meta-analysis.
Xie S; Li S; Chen B; Zhu Q; Xu L; Li F
Clin Rheumatol; 2021 Nov; 40(11):4533-4543. PubMed ID: 34189672
[TBL] [Abstract][Full Text] [Related]
12. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study.
van Wesemael TJ; Ajeganova S; Humphreys J; Terao C; Muhammad A; Symmons DP; MacGregor AJ; Hafström I; Trouw LA; van der Helm-van Mil AH; Huizinga TW; Mimori T; Toes RE; Matsuda F; Svensson B; Verstappen SM; van der Woude D
Arthritis Res Ther; 2016 Dec; 18(1):285. PubMed ID: 27906045
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and predictive value of high-positive rheumatoid factor and anti-citrullinated protein antibody levels in nonarthritic patients with chronic hepatitis C infection.
Lin KM; Chen WM; Tung SY; Wei KL; Shen CH; Chang TS; Chang PJ
Int J Rheum Dis; 2019 Jan; 22(1):116-120. PubMed ID: 30338656
[TBL] [Abstract][Full Text] [Related]
14. Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis.
Oka S; Higuchi T; Furukawa H; Shimada K; Okamoto A; Hashimoto A; Komiya A; Saisho K; Yoshikawa N; Katayama M; Matsui T; Fukui N; Migita K; Tohma S
BMC Musculoskelet Disord; 2022 Jan; 23(1):46. PubMed ID: 35027028
[TBL] [Abstract][Full Text] [Related]
15. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis.
Young KA; Deane KD; Derber LA; Hughes-Austin JM; Wagner CA; Sokolove J; Weisman MH; Buckner JH; Mikuls TR; O'Dell JR; Keating RM; Gregersen PK; Robinson WH; Holers VM; Norris JM
Arthritis Rheum; 2013 Aug; 65(8):1995-2004. PubMed ID: 23754702
[TBL] [Abstract][Full Text] [Related]
16. Association of the serological status of rheumatoid arthritis patients with two circulating protein biomarkers: A useful tool for precision medicine strategies.
Ruiz-Romero C; Fernández-Puente P; González L; Illiano A; Lourido L; Paz R; Quaranta P; Perez-Pampín E; González A; Blanco FJ; Calamia V
Front Med (Lausanne); 2022; 9():963540. PubMed ID: 36388911
[TBL] [Abstract][Full Text] [Related]
17. Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis.
Bugatti S; Bogliolo L; Vitolo B; Manzo A; Montecucco C; Caporali R
Arthritis Res Ther; 2016 Oct; 18(1):226. PubMed ID: 27716332
[TBL] [Abstract][Full Text] [Related]
18. Repeat serological testing for anti-citrullinated peptide antibody after commencement of therapy is not helpful in patients with seronegative rheumatoid arthritis.
Reid AB; Wiese M; McWilliams L; Metcalf R; Hall C; Lee A; Hill C; Wechalekar M; Cleland L; Proudman SM
Intern Med J; 2020 Jul; 50(7):818-822. PubMed ID: 32656986
[TBL] [Abstract][Full Text] [Related]
19. The association between anti-carbamylated protein (anti-CarP) antibodies and radiographic progression in early rheumatoid arthritis: a study exploring replication and the added value to ACPA and rheumatoid factor.
Ajeganova S; van Steenbergen HW; Verheul MK; Forslind K; Hafström I; Toes RE; Huizinga TW; Svensson B; Trouw LA; van der Helm-van Mil AH
Ann Rheum Dis; 2017 Jan; 76(1):112-118. PubMed ID: 27117699
[TBL] [Abstract][Full Text] [Related]
20. Anti-citrullinated protein antibody positive rheumatoid arthritis is primarily determined by rheumatoid factor titre and the shared epitope rather than smoking per se.
Murphy D; Mattey D; Hutchinson D
PLoS One; 2017; 12(7):e0180655. PubMed ID: 28708862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]